Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,004,286

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,004,286
Title: Particle delivery
Abstract:A needleless syringe, in which particles of a therapeutic agent are entrained in a high pressure gas flow, has a nozzle surrounded by a shroud silencer through which gas reflected from the target surface may be vented to atmosphere while retaining any particles reflected in the gas.
Inventor(s): Bellhouse; Brian John (Oxfordshire, GB), Potter; Charles David Ogilvy (Oxon, GB), Greenford; John Christopher (Oxfordshire, GB)
Assignee: PowderJect Research Limited (GB)
Application Number:09/156,421
Patent Claim Types:
see list of patent claims
Delivery; Device;

Drugs Protected by US Patent 6,004,286

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,004,286

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9605690Mar 19, 1996

International Family Members for US Patent 6,004,286

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 1935997   Start Trial
Canada 2247142   Start Trial
Germany 69729634   Start Trial
European Patent Office 0892649   Start Trial
United Kingdom 9605690   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.